Blackstone Equity Method Investments increased by 0.6% to $415.80M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.2%, from $357.90M to $415.80M. Over 4 years (FY 2020 to FY 2024), Equity Method Investments shows an upward trend with a 43.1% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $113.10M | $211.40M | $2.50B | $2.50B | $2.50B | $362.70M | $375.50M | $371.50M | $378.50M | $380.20M | $333.30M | $333.90M | $348.70M | $357.90M | $356.30M | $420.10M | $413.20M | $415.80M |
| QoQ Change | — | +86.9% | >999% | +0.0% | +0.0% | -85.5% | +3.5% | -1.1% | +1.9% | +0.4% | -12.3% | +0.2% | +4.4% | +2.6% | -0.4% | +17.9% | -1.6% | +0.6% |
| YoY Change | — | — | — | — | >999% | +71.6% | -85.0% | -85.1% | -84.9% | +4.8% | -11.2% | -10.1% | -7.9% | -5.9% | +6.9% | +25.8% | +18.5% | +16.2% |